Peanut Butter.

Peanuts carry phytic acid, which binds zinc in the gut lumen into a complex humans cannot cleave without phytase. A zinc dose taken with a large phytate load is absorbed less well.

Phytate in peanuts binds non-heme iron and holds it in an insoluble complex through the small intestine. The effect is dose dependent and is offset in part when ascorbate is present in the same meal.

Peanuts supply alpha-tocopherol in a fully lipid matrix, close to the ideal condition for tocopherol uptake. The same fat also carries added tocopherol into micelles.

Cholecalciferol needs a fat-containing meal to be packaged into bile salt micelles. Taking it with a high-fat spread such as peanut butter raises the absorbed fraction over a fasted dose.

Peanuts are a meaningful magnesium source, though a share of that magnesium is bound as phytate salts and less available than the raw figure suggests. The same phytate also limits added magnesium taken in the same meal.

Peanuts are among the denser plant sources of niacin, and the niacin is not heavily bound to indigestible complexes as it is in maize. A serving contributes a real share of daily intake.

Peanut protein is unusually rich in arginine relative to lysine. That skew is why peanuts are cited as a whole-food arginine source for nitric oxide substrate.

Arginine and lysine cross the intestinal wall on the same y+ cationic transporter, so a high-arginine food eaten with a lysine dose creates competition at that carrier. Peanut protein is also low in lysine, which is why lysine is the limiting amino acid in peanut-based diets.

Carotenoid absorption depends on dietary fat being present in the same meal to form the mixed micelles that carry them across the enterocyte membrane. Peanut butter supplies both the fat and the emulsified matrix. This is a meal-composition effect, well characterised for carotenoids generally.

Lutein is a xanthophyll and shares the carotenoid absorption route, which needs lipid in the gut lumen. A fat-containing food eaten with a lutein source raises the fraction that reaches circulation. Peanut butter is one of the ordinary ways this is done at a meal.

Lycopene is highly lipophilic and its appearance in plasma tracks the fat content of the meal it was eaten with. The peanut lipid fraction is largely oleic and linoleic acid, both effective micelle formers. The measured endpoint in this literature is a plasma concentration, which is a marker of absorption rather than a health outcome.

Phylloquinone is fat-soluble and its uptake from a plant source is low when the meal carries little fat. Adding a fat source at the same meal raises the absorbed fraction. Peanut butter contributes roughly half its mass as lipid, which is more than enough for this purpose.

Menaquinone-7 follows the same fat-dependent absorption route as other vitamin K forms. Taking it with a fat-containing food rather than on an empty stomach is standard formulation advice for this reason. The interaction is with dietary fat in general, and peanut butter is one convenient carrier.

Coenzyme Q10 is a large, poorly water-soluble quinone whose absorption is limited by micelle formation. Co-ingestion with dietary fat raises plasma appearance. The relevant variable is the fat, not anything peanut-specific.

Curcuminoids are lipophilic and poorly absorbed from an aqueous vehicle. A fat-containing food gives them a lipid phase to partition into during digestion. This addresses solubility only, and does not affect the rapid conjugation that limits curcumin exposure after absorption.

Astaxanthin is a xanthophyll carotenoid with the same fat dependence as lutein and zeaxanthin. Fat at the meal raises the absorbed fraction relative to a fasted dose. Peanut butter is a practical food-based way to supply it.

The iron in peanuts is non-heme and sits in a matrix that also carries phytate. Ascorbate reduces ferric to ferrous iron and forms a soluble complex that resists phytate binding, which raises the absorbed fraction from a plant-source meal. The effect is meal-specific and does not carry over to iron eaten at a later meal.

Peanuts carry inositol hexaphosphate, which binds iron, zinc and calcium in the gut lumen and lowers their absorption. Phytase hydrolyses the phosphate groups off that ring and releases the bound minerals. Human digestive secretions contain little phytase of their own, which is why added or microbial phytase changes the outcome.

Calcium and phytate form a poorly soluble ternary complex with zinc and iron, so a high-calcium dose taken with a phytate-containing food lowers the absorption of both minerals. The effect runs in both directions and is meal-bound. Separating a calcium dose from a peanut-based meal is the usual practical response.

Peanuts are a notable dietary manganese source, and manganese and non-heme iron share the divalent metal transporter DMT1 at the brush border. A large manganese load and an iron dose at the same meal compete for the same carrier. This matters most for people already managing low iron status.

Peanut protein is limiting in the sulphur amino acids methionine and cysteine, which caps the biological value of peanut protein eaten alone. Combining it with a methionine-richer protein source lifts the limiting amino acid rather than adding more total nitrogen. This is classic protein complementation, not a novel interaction.

Whey is high in leucine, lysine and the sulphur amino acids, exactly the residues peanut protein is short of. Blending the two produces a mixture with a better-balanced essential amino acid profile than either alone at the same total protein. The gain comes from composition, not from any absorption effect.

Peanut protein contributes tryptophan, the precursor for serotonin and downstream melatonin synthesis, and a randomised trial tested nightly peanut butter intake against self-reported sleep measures in firefighters. Those outcomes were questionnaire-based, so they index perceived sleep rather than measured sleep architecture. Tryptophan from a mixed protein also competes with other large neutral amino acids for brain uptake, which limits how much a protein food shifts central tryptophan.

Peanut kernels and especially the skins carry stilbenes including resveratrol, and an analytical study of peanut kernels and coats measured the total antioxidant capacity of both fractions. Peanut butter made with the skins retains more of that fraction than a blanched product. The measurement is chemical capacity in the laboratory, not an effect measured in people.

Fat and viscous soluble fibre both slow gastric emptying, and each blunts the rise in blood glucose after a carbohydrate-containing meal. Taken together at the same meal the two act on the same variable through different routes. Blood glucose here is a marker measured after a meal, not a clinical endpoint.

Peanuts are among the plant foods that contribute meaningful biotin to the diet. A peanut-based food therefore adds to biotin intake alongside any supplemental source rather than interacting with it. Nothing in the peanut matrix is known to impair biotin uptake.